Two Sigma Securities’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,165
Closed -$11.3K 1891
2025
Q4
$11.3K Buy
+11,165
New +$13.9K ﹤0.01% 1275
2025
Q1
Sell
-11,461
Closed -$28.3K 1799
2024
Q4
$28.3K Buy
+11,461
New +$22K ﹤0.01% 1257
2024
Q3
Sell
-12,070
Closed -$21K 3213
2024
Q2
$21K Buy
+12,070
New +$17.7K ﹤0.01% 2686
2021
Q4
Sell
-22,553
Closed -$58K 1771
2021
Q3
$58K Buy
+22,553
New +$59.4K ﹤0.01% 1370
2019
Q3
Sell
-17,708
Closed -$56K 2234
2019
Q2
$56K Buy
+17,708
New +$560K ﹤0.01% 1887

Other funds holding IFRX

Two Sigma Securities's IFRX Position: Q1 2026 in Review

Two Sigma Securities sold out of InflaRx (IFRX) in Q1 2026, closing a stake of 11,165 shares — an estimated $11.3K sold.

Two Sigma Securities first reported a position in IFRX in Q2 2019 and held it in 5 quarters. The position peaked at $58K in Q3 2021. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.

  • Two Sigma Securities reported no remaining InflaRx position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 11,165 InflaRx shares in Q1 2026, an estimated $11.3K.
  • Two Sigma Securities first reported a position in InflaRx in Q2 2019 and held it in 5 quarters.
  • Two Sigma Securities's InflaRx position peaked at $58K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.